Literature DB >> 2066108

Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.

G M Glenn1, L N Daniel, P Choyke, W M Linehan, E Oldfield, M B Gorin, S Hosoe, F Latif, G Weiss, M Walther.   

Abstract

As part of an attempt to locate the von Hippel-Lindau locus (VHL) on chromosome 3, we evaluated 41 families with von Hippel-Lindau disease from the United States and Canada. One large family was identified whose disease phenotype was distinct from typical VHL. The most common disease manifestation was pheochromocytoma occurring in 57% (27/47) of affected family members. Few (4/47) affected family members had symptomatic spinal or cerebellar hemangioblastomas; no affected family member had renal cell carcinoma (0/47) or pancreatic cysts (0/24). Previously, genetic analysis demonstrated that the disease manifestations in this family were linked to RAF1 and D3S18, markers shown to be linked to typical VHL. These results suggest that there are mutant alleles at the VHL locus associated with distinct tissue specificities.

Entities:  

Mesh:

Year:  1991        PMID: 2066108     DOI: 10.1007/BF00204184

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Pheochromocytoma; its relationship to the neurocutaneous syndromes.

Authors:  A S GLUSHIEN; M M MANSUY; D S LITTMAN
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

2.  Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.

Authors:  Y Nakamura; M Lathrop; M Leppert; M Dobbs; J Wasmuth; E Wolff; M Carlson; E Fujimoto; K Krapcho; T Sears
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

3.  Office fluorescein angioscopy.

Authors:  P Sinchai
Journal:  Ann Ophthalmol       Date:  1977-02

4.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

5.  Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps.

Authors:  M Leppert; R Burt; J P Hughes; W Samowitz; Y Nakamura; S Woodward; E Gardner; J M Lalouel; R White
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

6.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

7.  Von Hippel-Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy.

Authors:  R B Welch
Journal:  Trans Am Ophthalmol Soc       Date:  1970

8.  Confirmation of linkage in von Hippel-Lindau disease.

Authors:  J M Vance; K W Small; M A Jones; J M Stajich; L H Yamaoka; A D Roses; W Y Hung; M A Pericak-Vance
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

9.  von Hippel-Lindau disease: radiologic screening for visceral manifestations.

Authors:  P L Choyke; M R Filling-Katz; T H Shawker; M B Gorin; W D Travis; R Chang; B R Seizinger; A J Dwyer; W M Linehan
Journal:  Radiology       Date:  1990-03       Impact factor: 11.105

10.  Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

Authors:  R A Norum; R G Lafreniere; L W O'Neal; T F Nikolai; J P Delaney; J C Sisson; H Sobol; G M Lenoir; B A Ponder; H F Willard
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

View more
  17 in total

1.  Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.

Authors:  M T Sgambati; C Stolle; P L Choyke; M M Walther; B Zbar; W M Linehan; G M Glenn
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

3.  Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.

Authors:  Sarah M Nielsen; Wendy S Rubinstein; Darcy L Thull; Michaele J Armstrong; Eleanor Feingold; Michael T Stang; James R Gnarra; Sally E Carty
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

4.  VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality.

Authors:  B U Bender; C Eng; M Olschewski; D P Berger; J Laubenberger; C Altehöfer; G Kirste; M Orszagh; V van Velthoven; H Miosczka; D Schmidt; H P Neumann
Journal:  J Med Genet       Date:  2001-08       Impact factor: 6.318

5.  A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.

Authors:  S Cingoz; R B van der Luijt; E Kurt; M Apaydin; I Akkol; Mihriban Heval Ozgen
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

6.  Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

Authors:  H Brauch; T Kishida; D Glavac; F Chen; F Pausch; H Höfler; F Latif; M I Lerman; B Zbar; H P Neumann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.

Authors:  H J Decker; C Neuhaus; A Jauch; M Speicher; T Ried; M Bujard; H Brauch; S Störkel; M Stöckle; B Seliger; C Huber
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

8.  Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p.

Authors:  S C Szymanski; H Hummerich; F Latif; M I Lerman; G Röhrborn; E Schröder
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

9.  Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3.

Authors:  F Latif; W S Modi; F M Duh; L Schmidt; H Li; L Geil; M L Orcutt; A Heppell-Parton; P H Rabbitts; W M Linehan
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

10.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.